PD-L1 expression combined with immune phenotype is a potential predictor of outcome with PD-1 inhibitor monotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Saved in:
| Title: | PD-L1 expression combined with immune phenotype is a potential predictor of outcome with PD-1 inhibitor monotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma. |
|---|---|
| Authors: | Kim DH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Koh J; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Ahn JS; Lunit Inc, Seoul, Republic of Korea., Moon J; Lunit Inc, Seoul, Republic of Korea., Kang M; Lunit Inc, Seoul, Republic of Korea., Park G; Lunit Inc, Seoul, Republic of Korea., Lim Y; Lunit Inc, Seoul, Republic of Korea., Ock CY; Lunit Inc, Seoul, Republic of Korea., Jeon YK; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Jung KC; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea., Ahn SH; Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Republic of Korea., Chung EJ; Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Republic of Korea., Kwon SK; Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Republic of Korea., Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: bhumsuk@snu.ac.kr. |
| Source: | Oral surgery, oral medicine, oral pathology and oral radiology [Oral Surg Oral Med Oral Pathol Oral Radiol] 2026 May; Vol. 141 (5), pp. 679-689. Date of Electronic Publication: 2025 Dec 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101576782 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-4411 (Electronic) NLM ISO Abbreviation: Oral Surg Oral Med Oral Pathol Oral Radiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41486033 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PD-L1 expression combined with immune phenotype is a potential predictor of outcome with PD-1 inhibitor monotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kim+DH%22">Kim DH</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Koh+J%22">Koh J</searchLink>; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+JS%22">Ahn JS</searchLink>; Lunit Inc, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Moon+J%22">Moon J</searchLink>; Lunit Inc, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+M%22">Kang M</searchLink>; Lunit Inc, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+G%22">Park G</searchLink>; Lunit Inc, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lim+Y%22">Lim Y</searchLink>; Lunit Inc, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ock+CY%22">Ock CY</searchLink>; Lunit Inc, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeon+YK%22">Jeon YK</searchLink>; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jung+KC%22">Jung KC</searchLink>; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+SH%22">Ahn SH</searchLink>; Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chung+EJ%22">Chung EJ</searchLink>; Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kwon+SK%22">Kwon SK</searchLink>; Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Keam+B%22">Keam B</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: bhumsuk@snu.ac.kr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101576782%22">Oral surgery, oral medicine, oral pathology and oral radiology</searchLink> [Oral Surg Oral Med Oral Pathol Oral Radiol] 2026 May; Vol. 141 (5), pp. 679-689. <i>Date of Electronic Publication: </i>2025 Dec 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101576782 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2212-4411 (Electronic) <i>NLM ISO Abbreviation: </i>Oral Surg Oral Med Oral Pathol Oral Radiol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41486033 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.oooo.2025.11.018 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 679 Titles: – TitleFull: PD-L1 expression combined with immune phenotype is a potential predictor of outcome with PD-1 inhibitor monotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kim DH – PersonEntity: Name: NameFull: Koh J – PersonEntity: Name: NameFull: Ahn JS – PersonEntity: Name: NameFull: Moon J – PersonEntity: Name: NameFull: Kang M – PersonEntity: Name: NameFull: Park G – PersonEntity: Name: NameFull: Lim Y – PersonEntity: Name: NameFull: Ock CY – PersonEntity: Name: NameFull: Jeon YK – PersonEntity: Name: NameFull: Jung KC – PersonEntity: Name: NameFull: Ahn SH – PersonEntity: Name: NameFull: Chung EJ – PersonEntity: Name: NameFull: Kwon SK – PersonEntity: Name: NameFull: Keam B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2212-4411 Numbering: – Type: volume Value: 141 – Type: issue Value: 5 Titles: – TitleFull: Oral surgery, oral medicine, oral pathology and oral radiology Type: main |
| ResultId | 1 |
